| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = -$586 ) |
| | 2026 | 2023 | CORIDEA, LLC | 345 PARK AVE S FL 3 | NEW YORK | NY | 10010-1707 | NEW YORK | USA | UG3DA058439 | Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose | 000 | 1 | NIH | 2/18/2026 | $0 |
| | 2026 | 2022 | CORIDEA, LLC | 345 PARK AVE S FL 3 | NEW YORK | NY | 10010-1707 | NEW YORK | USA | R44CA239829 | Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation | 000 | 3 | NIH | 2/18/2026 | -$586 |
|
| Issue Date FY: 2025 ( Subtotal = $3,670,809 ) |
| | 2025 | 2025 | CORIDEA, LLC | 345 PARK AVE S FL 3 | NEW YORK | NY | 10010-1707 | NEW YORK | USA | UH3DA058439 | Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose | 000 | 2 | NIH | 9/15/2025 | $2,544,126 |
| | 2025 | 2025 | CORIDEA, LLC | 345 PARK AVE S FL 3 | NEW YORK | NY | 10010-1707 | NEW YORK | USA | R44HL178050 | ENT-based Approach to Cervical Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea | 001 | 1 | NIH | 9/19/2025 | -$982,086 |
| | 2025 | 2025 | CORIDEA, LLC | 345 PARK AVE S FL 3 | NEW YORK | NY | 10010-1707 | NEW YORK | USA | R44HL178050 | ENT-based Approach to Cervical Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea | 000 | 1 | NIH | 9/11/2025 | $982,086 |
| | 2025 | 2025 | CORIDEA, LLC | 345 PARK AVE S FL 3 | NEW YORK | NY | 10010-1707 | NEW YORK | USA | R44HL178050 | ENT-based Approach to Cervical Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea | 001 | 1 | NIH | 9/19/2025 | $982,086 |
| | 2025 | 2025 | CORIDEA, LLC | 345 PARK AVE S FL 3 | NEW YORK | NY | 10010-1707 | NEW YORK | USA | UH3DA058439 | Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose | 001 | 2 | NIH | 9/18/2025 | $149,883 |
| | 2025 | 2022 | CORIDEA LLC | 175 CEDAR LN | TEANECK | NJ | 07666-4315 | BERGEN | USA | R44CA239829 | Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation | 000 | 3 | NIH | 11/21/2024 | $0 |
| | 2025 | 2022 | CORIDEA, LLC | 345 PARK AVE S FL 3 | NEW YORK | NY | 10010-1707 | NEW YORK | USA | R44HL149550 | Endobronchial Supervalve for the Treatment of Emphysema | 000 | 3 | NIH | 4/24/2025 | -$5,286 |
|
| Issue Date FY: 2024 ( Subtotal = $1,339,530 ) |
| | 2024 | 2024 | CORIDEA LLC | 175 CEDAR LN | TEANECK | NJ | 07666-4315 | BERGEN | USA | R44HL167428 | Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy | 001 | 2 | NIH | 4/22/2024 | $122,700 |
| | 2024 | 2024 | CORIDEA LLC | 175 CEDAR LN | TEANECK | NJ | 07666-4315 | BERGEN | USA | R44HL167428 | Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy | 000 | 2 | NIH | 4/19/2024 | $941,991 |
| | 2024 | 2024 | CORIDEA LLC | 175 CEDAR LN | TEANECK | NJ | 07666-4315 | BERGEN | USA | R43GM154625 | Stellate Ganglion Stimulation in Septic Shock to Improve Hemodynamics and Vasopressor Requirements | 000 | 1 | NIH | 6/5/2024 | $274,839 |
| | 2024 | 2023 | CORIDEA LLC | 175 CEDAR LN | TEANECK | NJ | 07666-4315 | BERGEN | USA | UG3DA058439 | Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose | 001 | 1 | NIH | 4/18/2024 | $0 |
| | 2024 | 2023 | CORIDEA LLC | 154 W 14TH ST | NEW YORK | NY | 10011-7307 | NEW YORK | USA | UG3DA058439 | Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose | 000 | 1 | NIH | 11/10/2023 | $0 |
| | 2024 | 2022 | CORIDEA LLC | 154 W 14TH ST | NEW YORK | NY | 10011-7307 | NEW YORK | USA | R44HL149550 | Endobronchial Supervalve for the Treatment of Emphysema | 000 | 3 | NIH | 3/8/2024 | $0 |
| | 2024 | 2021 | CORIDEA LLC | 175 CEDAR LN | TEANECK | NJ | 07666-4315 | BERGEN | USA | R43DA055401 | On Demand Electrostimulation | 000 | 1 | NIH | 3/4/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,834,567 ) |
| | 2023 | 2023 | CORIDEA LLC | 154 W 14TH ST | NEW YORK | NY | 10011-7307 | NEW YORK | USA | R44HL167428 | Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy | 001 | 1 | NIH | 8/1/2023 | $0 |
| | 2023 | 2023 | CORIDEA LLC | 154 W 14TH ST | NEW YORK | NY | 10011-7307 | NEW YORK | USA | R44HL167428 | Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy | 000 | 1 | NIH | 4/30/2023 | $784,548 |
| | 2023 | 2023 | CORIDEA LLC | 154 W 14TH ST | NEW YORK | NY | 10011-7307 | NEW YORK | USA | UG3DA058439 | Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose | 000 | 1 | NIH | 9/1/2023 | $927,319 |
| | 2023 | 2023 | CORIDEA LLC | 154 W 14TH ST | NEW YORK | NY | 10011-7307 | NEW YORK | USA | R44HL167428 | Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy | 002 | 1 | NIH | 8/11/2023 | $122,700 |
| | 2023 | 2020 | CORIDEA LLC | 154 W 14TH ST | NEW YORK | NY | 10011-7307 | NEW YORK | USA | R44HL127771 | Painless Defibrillation | 000 | 5 | NIH | 11/15/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $1,826,397 ) |
| | 2022 | 2022 | CORIDEA LLC | 154 W 14TH ST | NEW YORK | NY | 10011-7307 | NEW YORK | USA | R44CA239829 | Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation | 000 | 3 | NIH | 8/18/2022 | $784,016 |
| | 2022 | 2022 | CORIDEA LLC | 154 W 14TH ST | NEW YORK | NY | 10011-7307 | NEW YORK | USA | R43DA055401 | On Demand Electrostimulation | 000 | 1 | NIH | 4/13/2022 | $54,863 |
| | 2022 | 2022 | CORIDEA, LLC | 336 W 37TH ST RM 720 | NEW YORK | NY | 10018-4212 | NEW YORK | USA | R44HL149550 | Endobronchial Supervalve for the Treatment of Emphysema | 000 | 3 | NIH | 12/10/2021 | $988,194 |
| | 2022 | 2021 | CORIDEA LLC | 154 W 14TH ST | NEW YORK | NY | 10011-7307 | NEW YORK | USA | R43DA055401 | On Demand Electrostimulation | 001 | 1 | NIH | 8/25/2022 | $0 |
| | 2022 | 2019 | CORIDEA LLC | 154 W 14TH ST | NEW YORK | NY | 10011-7307 | NEW YORK | USA | R44HL135957 | Minimally?Invasive?Cardiac?Sympathetic Denervation for Malignant Ventricular?Arrhythmia | 000 | 3 | NIH | 7/14/2022 | $0 |
| | 2022 | 2019 | CORIDEA LLC | 154 W 14TH ST | NEW YORK | NY | 10011-7307 | NEW YORK | USA | R43HL144266 | Minimally Invasive Cardio-Pulmonary Plexus Block for the Treatment of Pulmonary Hypertension | 001 | 1 | NIH | 6/29/2022 | -$676 |
| | 2022 | 2019 | CORIDEA LLC | 154 W 14TH ST | NEW YORK | NY | 10011-7307 | NEW YORK | USA | R43HL144266 | Minimally Invasive Cardio-Pulmonary Plexus Block for the Treatment of Pulmonary Hypertension | 000 | 1 | NIH | 11/4/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,939,229 ) |
| | 2021 | 2021 | CORIDEA, LLC | 336 W 37TH ST RM 720 | NEW YORK | NY | 10018-4212 | NEW YORK | USA | R43DA055401 | On Demand Electrostimulation | 000 | 1 | NIH | 9/22/2021 | $223,921 |
| | 2021 | 2021 | CORIDEA, LLC | 336 W 37TH ST RM 720 | NEW YORK | NY | 10018-4212 | NEW YORK | USA | R44CA239829 | Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation | 000 | 2 | NIH | 9/24/2021 | $783,896 |
| | 2021 | 2021 | CORIDEA, LLC | 336 W 37TH ST RM 720 | NEW YORK | NY | 10018-4212 | NEW YORK | USA | R44HL149550 | Endobronchial Supervalve for the Treatment of Emphysema | 000 | 2 | NIH | 11/24/2020 | $805,212 |
| | 2021 | 2021 | CORIDEA, LLC | 336 W 37TH ST RM 720 | NEW YORK | NY | 10018-4212 | NEW YORK | USA | R44HL149550 | Endobronchial Supervalve for the Treatment of Emphysema | 001 | 2 | NIH | 2/1/2021 | $126,200 |
| | 2021 | 2020 | CORIDEA, LLC | 336 W 37TH ST RM 720 | NEW YORK | NY | 10018-4212 | NEW YORK | USA | R44HL149550 | Endobronchial Supervalve for the Treatment of Emphysema | 002 | 1 | NIH | 6/28/2021 | $0 |
| | 2021 | 2019 | CORIDEA, LLC | 336 W 37TH ST RM 720 | NEW YORK | NY | 10018-4212 | NEW YORK | USA | R44HL135957 | Minimally?Invasive?Cardiac?Sympathetic Denervation for Malignant Ventricular?Arrhythmia | 000 | 3 | NIH | 7/5/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,224,058 ) |
| | 2020 | 2020 | CORIDEA, LLC | 336 W 37TH ST RM 720 | NEW YORK | NY | 10018-4212 | NEW YORK | USA | R44HL127771 | Painless Defibrillation | 000 | 5 | NIH | 5/2/2020 | $982,600 |
| | 2020 | 2020 | CORIDEA, LLC | 336 W 37TH ST RM 720 | NEW YORK | NY | 10018-4212 | NEW YORK | USA | R44HL149550 | Endobronchial Supervalve for the Treatment of Emphysema | 001 | 1 | NIH | 8/6/2020 | $0 |
| | 2020 | 2020 | CORIDEA, LLC | 336 W 37TH ST RM 720 | NEW YORK | NY | 10018-4212 | NEW YORK | USA | R44HL149550 | Endobronchial Supervalve for the Treatment of Emphysema | 000 | 1 | NIH | 4/10/2020 | $246,415 |
| | 2020 | 2019 | CORIDEA, LLC | 336 W 37TH ST RM 720 | NEW YORK | NY | 10018-4212 | NEW YORK | USA | R43HL144266 | Minimally Invasive Cardio-Pulmonary Plexus Block for the Treatment of Pulmonary Hypertension | 000 | 1 | NIH | 7/30/2020 | $0 |
| | 2020 | 2019 | CORIDEA, LLC | 336 W 37TH ST RM 720 | NEW YORK | NY | 10018-4212 | NEW YORK | USA | R43CA239829 | Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation | 000 | 1 | NIH | 1/28/2020 | -$4,957 |
|
| Issue Date FY: 2019 ( Subtotal = $2,159,292 ) (Continued on the next page) |
| | 2019 | 2019 | CORIDEA, LLC | 336 W 37TH ST RM 720 | NEW YORK | NY | 10018-4212 | NEW YORK | USA | R44HL135957 | Minimally?Invasive?Cardiac?Sympathetic Denervation for Malignant Ventricular?Arrhythmia | 001 | 3 | NIH | 2/25/2019 | $742,382 |
| | 2019 | 2019 | CORIDEA, LLC | 336 W 37TH ST RM 720 | NEW YORK | NY | 10018-4212 | NEW YORK | USA | R43HL144266 | Minimally Invasive Cardio-Pulmonary Plexus Block for the Treatment of Pulmonary Hypertension | 000 | 1 | NIH | 3/19/2019 | $224,791 |
| | 2019 | 2019 | CORIDEA, LLC | 336 W 37TH ST RM 720 | NEW YORK | NY | 10018-4212 | NEW YORK | USA | R43CA239829 | Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation | 000 | 1 | NIH | 3/26/2019 | $224,929 |
|
